Innate mechanisms for virus-induced diabetes
病毒诱发糖尿病的先天机制
基本信息
- 批准号:9522130
- 负责人:
- 金额:$ 50.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-12 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntidiabetic DrugsApoptosisAutoimmune DiabetesAutophagocytosisB-LymphocytesBeta CellCell DeathCell LineCell SurvivalCell physiologyCellsCessation of lifeChronicClinicalCoxsackie B VirusesDevelopmentDiabetes MellitusDiseaseDown-RegulationDuodenumElementsEnterovirusEnvironmental Risk FactorEtiologyExhibitsExpression ProfilingFunctional disorderGene ExpressionGene Expression ProfileGene TargetingGenesGeneticGenetic VariationGoalsHomeoboxHumanHuman GeneticsHyperglycemiaImmuneImmune responseImmune signalingImmunodeficient MouseIn VitroInfectionInflammatoryInnate Immune ResponseInsulinInsulin-Dependent Diabetes MellitusInterferon Type IInterferonsInvestigationIslet CellLaboratory AnimalsLifeLongitudinal StudiesMeasuresMediatingModelingMonitorMusMutationPancreasPathogenesisPathway interactionsPredispositionPreventive vaccineProductionPropertyRegulationRoleSerotypingSevere Combined ImmunodeficiencySignal PathwaySite-Directed MutagenesisSpecificityStructure of beta Cell of isletT-LymphocyteTestingTransplantationVaccinesViralViral ProteinsVirusVirus ActivationVirus DiseasesWhole Organismadaptive immune responsechronic infectioncytokinedesigndiabeticdiabetogenicendoplasmic reticulum stressenvironmental enrichment for laboratory animalsepidemiologic dataglycemic controlhuman tissuein vivoinfected B cellinsulin promoter factor 1isletmouse modelmutantnoveloverexpressionpathogenresearch studyresponsetranscription factorviral RNAvirus developmentvirus genetics
项目摘要
Project Summary/Abstract
Viral infection has been associated with the development of type 1 diabetes (T1D). Studying virus-
associated diabetes in laboratory animals has been problematic due to differences in host species-specific
susceptibility and immune responses to viral pathogens including Coxsackie B virus (CVB). In order to better
evaluate CVB's impact on causing human T1D, we developed a viral infection model in immunodeficient mice
bearing human islet grafts that are crucial for glycemic control. In this model, infection with CVB4 strain JVB
leads to diabetes in nearly half of all infected animals. Human islet grafts from infected mice contained viral
RNA, expressed viral protein, and exhibited mild to moderate cell degeneration compared to the islet grafts
from mock-infected mice. Gene expression profiles from the human grafts revealed induction of interferon-
stimulated genes and ER stress, as well as decreased expression of insulin and the transcription factor Pdx1.
In the proposed study, we will use this human islet-engrafted mouse model along with complementary studies
in cultured human beta cells to delineate the mechanisms of beta cell dysfunction and/or death following CVB
infection. We will compare different CVB strains as well as mutant viruses to identify which viruses are more or
less diabetogenic. The ultimate goal is to design a preventive vaccine against TID.
项目摘要/摘要
病毒感染与1型糖尿病(T1D)的发展有关。研究病毒-
由于宿主物种的差异,实验室动物的相关糖尿病一直是有问题的
对包括柯萨奇B病毒(CVB)在内的病毒病原体的易感性和免疫反应。为了更好地
评估CVB对人类T1D的影响,我们在免疫缺陷小鼠中建立了病毒感染模型
携带对血糖控制至关重要的人类胰岛移植物。在该模型中,感染CVB4株JVB
导致近一半的受感染动物患上糖尿病。含有病毒的感染小鼠的人胰岛移植
RNA,表达病毒蛋白,与胰岛移植物相比,表现出轻度到中度的细胞变性
来自模拟感染的小鼠。人类移植物的基因表达谱显示干扰素的诱导-
刺激基因和内质网应激,以及胰岛素和转录因子Pdx1表达下降。
在拟议的研究中,我们将使用这种人类胰岛移植的小鼠模型以及补充研究。
在培养的人β细胞中描述CVB后β细胞功能障碍和/或死亡的机制
感染。我们将比较不同的CVB毒株以及突变病毒,以确定哪些病毒更多或更多
糖尿病诱因较少。最终目标是设计一种针对TID的预防性疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer P Wang其他文献
Jennifer P Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer P Wang', 18)}}的其他基金
Differential roles for type I interferon and inflammatory pathways in autoimmune diabetes
I 型干扰素和炎症通路在自身免疫性糖尿病中的不同作用
- 批准号:
10189495 - 财政年份:2018
- 资助金额:
$ 50.25万 - 项目类别:
Differential roles for type I interferon and inflammatory pathways in autoimmune diabetes
I 型干扰素和炎症通路在自身免疫性糖尿病中的不同作用
- 批准号:
10431826 - 财政年份:2018
- 资助金额:
$ 50.25万 - 项目类别:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
MDA5 在病毒介导的 I 型糖尿病中的作用评估
- 批准号:
8868007 - 财政年份:2011
- 资助金额:
$ 50.25万 - 项目类别:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
MDA5 在病毒介导的 I 型糖尿病中的作用评估
- 批准号:
8298127 - 财政年份:2011
- 资助金额:
$ 50.25万 - 项目类别:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
MDA5 在病毒介导的 I 型糖尿病中的作用评估
- 批准号:
8024745 - 财政年份:2011
- 资助金额:
$ 50.25万 - 项目类别:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
MDA5 在病毒介导的 I 型糖尿病中的作用评估
- 批准号:
8677682 - 财政年份:2011
- 资助金额:
$ 50.25万 - 项目类别:
Evaluation of the role of MDA5 in virus-mediated type I diabetes
MDA5 在病毒介导的 I 型糖尿病中的作用评估
- 批准号:
8485536 - 财政年份:2011
- 资助金额:
$ 50.25万 - 项目类别:
相似海外基金
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10679095 - 财政年份:2022
- 资助金额:
$ 50.25万 - 项目类别:
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10526807 - 财政年份:2022
- 资助金额:
$ 50.25万 - 项目类别:
Epidemiologic studies of antidiabetic drugs and cancer risk: TMLE method, bias analysis and Mendelian randomization
抗糖尿病药物与癌症风险的流行病学研究:TMLE 方法、偏倚分析和孟德尔随机化
- 批准号:
21K10500 - 财政年份:2021
- 资助金额:
$ 50.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanical and histrogical analysis bone to implant contact in type2 diabetes rats model with antidiabetic drugs.
使用抗糖尿病药物的 2 型糖尿病大鼠模型中骨与种植体接触的机械和组织学分析。
- 批准号:
26462931 - 财政年份:2014
- 资助金额:
$ 50.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synergistic activity of combination thrapies using 4-hydroxisoleucine (ID1101) and other T2D antidiabetic drugs.
使用 4-羟基异亮氨酸 (ID1101) 和其他 T2D 抗糖尿病药物的联合疗法的协同活性。
- 批准号:
300267-2003 - 财政年份:2006
- 资助金额:
$ 50.25万 - 项目类别:
Industrial Research Fellowships
Synergistic activity of combination thrapies using 4-hydroxisoleucine (ID1101) and other T2D antidiabetic drugs.
使用 4-羟基异亮氨酸 (ID1101) 和其他 T2D 抗糖尿病药物的联合疗法的协同活性。
- 批准号:
300267-2003 - 财政年份:2005
- 资助金额:
$ 50.25万 - 项目类别:
Industrial Research Fellowships
Synergistic activity of combination thrapies using 4-hydroxisoleucine (ID1101) and other T2D antidiabetic drugs.
使用 4-羟基异亮氨酸 (ID1101) 和其他 T2D 抗糖尿病药物的联合疗法的协同活性。
- 批准号:
300267-2003 - 财政年份:2004
- 资助金额:
$ 50.25万 - 项目类别:
Industrial Research Fellowships